Cost-effectiveness of Sativex in multiple sclerosis spasticity: new data and application to Italy
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Cost-effectiveness of Sativex in multiple sclerosis spasticity: new data and application to Italy
Authors
Keywords
-
Journal
Expert Review of Pharmacoeconomics & Outcomes Research
Volume 15, Issue 3, Pages 379-391
Publisher
Informa UK Limited
Online
2015-03-16
DOI
10.1586/14737167.2015.1025759
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Long-Term Effectiveness and Safety of Nabiximols (Tetrahydrocannabinol/Cannabidiol Oromucosal Spray) in Clinical Practice
- (2014) Peter Flachenecker et al. EUROPEAN NEUROLOGY
- Nabiximols (THC/CBD Oromucosal Spray, Sativex®) in Clinical Practice - Results of a Multicenter, Non-Interventional Study (MOVE 2) in Patients with Multiple Sclerosis Spasticity
- (2014) Peter Flachenecker et al. EUROPEAN NEUROLOGY
- Impact of Sativex®on quality of life and activities of daily living in patients with multiple sclerosis spasticity
- (2014) Rafael Arroyo et al. Journal of Comparative Effectiveness Research
- Costs and quality of life in multiple sclerosis patients with spasticity
- (2013) J. Svensson et al. ACTA NEUROLOGICA SCANDINAVICA
- Correlation between spasticity and quality of life in patients with multiple sclerosis: the CANDLE study
- (2013) Rafael Arroyo et al. INTERNATIONAL JOURNAL OF NEUROSCIENCE
- Experiencia clínica con los cannabinoides en la terapia de la espasticidad en la esclerosis múltiple
- (2013) L. Lorente Fernández et al. NEUROLOGIA
- Cost Effectiveness of Oromucosal Cannabis-Based Medicine (Sativex®) for Spasticity in Multiple Sclerosis
- (2012) Lanting Lu et al. PHARMACOECONOMICS
- Sativex® in multiple sclerosis spasticity: a cost–effectiveness model
- (2012) John Slof et al. Expert Review of Pharmacoeconomics & Outcomes Research
- A questionnaire survey of patients and carers of patients prescribed Sativex as an unlicensed medicine
- (2012) William G. Notcutt Primary Health Care Research and Development
- A randomized, double-blind, placebo-controlled, parallel-group, enriched-design study of nabiximols* (Sativex®), as add-on therapy, in subjects with refractory spasticity caused by multiple sclerosis
- (2011) A. Novotna et al. EUROPEAN JOURNAL OF NEUROLOGY
- A placebo-controlled, parallel-group, randomized withdrawal study of subjects with symptoms of spasticity due to multiple sclerosis who are receiving long-term Sativex® (nabiximols)
- (2011) W Notcutt et al. Multiple Sclerosis Journal
- Intrathecal baclofen in multiple sclerosis: Too little, too late?
- (2011) April Erwin et al. Multiple Sclerosis Journal
- Retrospective observational study of the management of multiple sclerosis patients with resistant spasticity in Spain: the ‘5E’ study
- (2011) Rafael Arroyo et al. Expert Review of Pharmacoeconomics & Outcomes Research
- Contribution of impaired mobility and general symptoms to the burden of multiple sclerosis
- (2010) Howard L. Zwibel ADVANCES IN THERAPY
- Rehabilitation in practice: Spasticity management
- (2010) VL Stevenson CLINICAL REHABILITATION
- Meta-analysis of the efficacy and safety of Sativex (nabiximols), on spasticity in people with multiple sclerosis
- (2010) Derick T Wade et al. Multiple Sclerosis Journal
- Evidence-Based Medicine and Multiple Sclerosis: Figures and Stories
- (2010) Jürg Kesselring NEUROEPIDEMIOLOGY
- Validity, reliability, and clinical importance of change in a 0—10 numeric rating scale measure of spasticity: a post hoc analysis of a randomized, double-blind, placebo-controlled trial
- (2008) John T. Farrar et al. CLINICAL THERAPEUTICS
- Long-Term Outcomes of Continuous Intrathecal Baclofen Infusion for Treatment of Spasticity: A Prospective Multicenter Follow-Up Study
- (2008) Elmar M. Delhaas et al. NEUROMODULATION
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started